CClinicalTrials.gg
CompletedNCT04133246MucoParUpdated Nov 20, 2025

Parenting Concerns in Patients With Cystic Fibrosis (MucoPar)

An interventional study of Focus group and Individual interview in Cystic Fibrosis, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-20.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to explore and collect the perceptions, expectations and needs of CF patients about parenting. This will be done in the context of several small groups of patients led by a psychologist who will ensure that all the participants express themselves; he will encourage them to develop their points of view, their divergences and their common points about what constitutes to be a parent.

The collected information should make it possible to develop and propose adapted medico-psycho-social interventions, if necessary, in connection with patient associations

Read the detailed description

Life expectancy has improved significantly in cystic fibrosis in recent years. From paediatric disease, it has become a disease of the adult, with the emergence of new issues, such as becoming a parent. Parent patients still face the risk of complications and death while their child is still young. However, there is very little data in the literature on parenting in cystic fibrosis.

Therefore, the purpose of this study is to explore and collect the perceptions, expectations and needs of CF patients and their spouses about parenting.

All patients with children, followed in 2 large adult CF centers, and their spouses will be invited to participate in a 6 to 10-person discussion group (focus group) led by a psychologist. He will ensure that all the participants express themselves and are encouraged to develop their points of view, their divergences and their common points about what constitutes to be a parent. The discussions will be recorded and transcribed.

Patients who cannot participate in groups (e.g. patients colonized with Burkholderia cepacia complex) but wish to be included in the study will benefit from an individual interview with the psychologist, also registered and transcribed. A thematic analysis will be carried out from the transcriptions of group contents. For individual interviews, phenomenological interpretative analysis (IPA) will be used. A synthesis of the two analyses will then be done.

The collected information should make it possible to develop and propose adapted medico-psycho-social interventions, if necessary, in connection with patient associations.

02

Conditions studied

  • Cystic Fibrosis

Browse trials for

Keywords

  • cystic fibrosis
  • parenthood
  • Psycho-social
  • Qualitative study
03

In context

Cystic Fibrosis

1,581 studies on the registry are indexed under Cystic Fibrosis; 190 are open to participants now.

This study's enrollment of 52 is above the median of 36 across 1,034 interventional studies indexed under Cystic Fibrosis.

Browse Cystic Fibrosis studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

For patients

  • Have cystic fibrosis
  • Be a parent and raise or have raised at least one child
  • Being followed in one of the two adult CF centers participating in the study

For CF patients' spouses

- Live with the CF patient participating in the study

For both CF patients and spouses

  • Being an adult (at least 18 y.o.)
  • Have a good level of French and good speaking skills

Exclusion criteria

Exclusion Criteria:

  • For both CF patients and spouses
  • Psychiatric pathology (borderline state, bipolarity and other psychotic disorders)
  • Serious somatic disease not related to cystic fibrosis
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
52 participants (actual)

Study arms

  • Other
    Group arm

    Includes subjects enrolled in focus groups

    Behavioral: Focus group

  • Other
    Interview arm

    Includes subjects with individual interviews

    Behavioral: Individual interview

Interventions

  • BehavioralFocus group

    Groups of 6 to 10 patients and spouses led by the psychologist about their parenthood lasting 2 hours

  • BehavioralIndividual interview

    Interview led by the psychologist about the patient's parenthood

06

What researchers measure

Primary outcomes

  1. Identification of themes about parenthood in CF from groups

    by thematic analysis. 8 to 10 focus groups composed of 5 to 10 persons are to be conducted until saturation of themes.

    Time frame: 2 years

Secondary outcomes

  1. Identification of themes about parenthood in CF from individual interviews

    by the IPA method. 20 individual interviews are to be conducted until saturation of themes

    Time frame: 2 years

  2. Occurrence of themes

    number of appearances of each theme, revealed by the 2 analyses, in the group arm on one hand, and in the interview arm on the other hand. The occurrence will provide information on the importance of each theme

    Time frame: 2 years

07

Study locations

2 sites
  • Cochin Hospital
    Paris, Île-de-France Region 75012, France
  • Foch Hospital
    Suresnes, Île-de-France Region 92150, France
08

References and documents

Publications

  • Jacob A, Hubert D, Brain C, Grenet D, Flahault C. Exploring the lived experiences of parents living with cystic fibrosis: A qualitative study. J Health Psychol. 2025 Aug;30(9):2183-2200. doi: 10.1177/13591053241307874. Epub 2025 Jan 7. PubMed 39764735 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04133246
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
URC-CIC Paris Descartes Necker Cochin
Responsible party
Sponsor
First posted
Oct 21, 2019
Start date
Sep 25, 2019
Primary completion
Dec 21, 2020
Completion
Dec 21, 2020
Last update
Nov 20, 2025

Study contacts

Cécile FLAHAULT, Ph.D
study chair · Assistance Publique - Hôpitaux de Paris
Dominique HUBERT, MD
principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion